What Actually Happens to Your Body Above 8,000 Metres

At sea level, the air around you contains approximately 21% oxygen. Your lungs breathe it in effortlessly. Your blood captures it. Your brain, your muscles, your organs all function within a narrow physiological range that billions of years of evolution have finely tuned for exactly this atmospheric pressure.

At 8,000 metres above sea level the altitude at which Mount Everest's death zone begins the air still contains 21% oxygen. But the atmospheric pressure has dropped to roughly one-third of what it is at sea level. This means your lungs inhale the same proportion of oxygen with every breath, but each breath contains only a third as many molecules. Your body is, in the most literal sense, slowly suffocating in open air.

This is not a metaphor. It is physiology. And it explains everything about what happens to human beings at extreme altitude.

The First Hour at Altitude: Acute Mountain Sickness

Most people ascending to 3,500 metres or above will experience some degree of Acute Mountain Sickness (AMS) a constellation of symptoms including headache, nausea, dizziness, fatigue, and disturbed sleep. The body interprets the drop in available oxygen as a crisis and responds accordingly: the heart beats faster to circulate more blood, breathing rate increases, and the kidneys begin excreting bicarbonate to adjust blood acidity.

These adjustments are useful in the short term but inadequate for sustained high altitude. The critical variable is time. Ascend too quickly and the body cannot adapt. Ascend slowly over days and weeks and a series of deeper physiological changes begin: the bone marrow produces more red blood cells, the muscles develop greater capillary density, and the brain learns to function with less oxygen per unit of blood.

This process is called acclimatisation. It is the reason that Everest expeditions last weeks and months rather than days.

The Death Zone: Above 8,000 Metres

The term death zone was coined by the Swiss physician Edouard Wyss-Dunant in 1953 the same year as the first summit to describe altitudes above which the human body cannot acclimatise no matter how long it spends there. Above 8,000 metres, the body is in permanent physiological decline. It cannot repair. It cannot adapt. It can only endure, for a limited time, before organ systems begin failing.

Everest's summit at 8,848 metres sits 848 metres above this threshold. Climbers at the top of the world are at the edge of what human biology can sustain.

Brain: The First Organ to Suffer

The brain consumes roughly 20% of the body's oxygen supply despite accounting for only 2% of its mass. At extreme altitude, cerebral oxygen delivery drops dramatically, producing cognitive effects that range from slowed thinking and impaired judgment to hallucinations and an inability to perform simple tasks.

Climbers in the death zone describe decision-making as feeling like trying to think through wet concrete. The calculation of whether to continue upward or turn back a life-or-death judgment that must be made while physically exhausted, oxygen-deprived, and often in deteriorating weather is made by a brain operating at severely reduced capacity.

High-Altitude Cerebral Edema (HACE)

In a subset of climbers, the brain's response to oxygen deprivation crosses a threshold into pathology. High-Altitude Cerebral Edema occurs when fluid leaks into the brain tissue itself, causing it to swell against the skull. Symptoms include severe ataxia (loss of coordination), confusion, and progressive loss of consciousness. Without immediate descent or treatment with a Gamow bag (portable hyperbaric chamber), HACE is fatal.

HACE can develop within hours, often at night when respiration slows during sleep. It is one of the primary reasons that high-altitude expedition doctors monitor climbers continuously and why experienced operators maintain 24-hour medical support at Base Camp.

High-Altitude Pulmonary Edema (HAPE)

HAPE is the leading cause of death from altitude illness. It involves the accumulation of fluid in the lungs a physiological response to hypoxia in which pulmonary blood vessels constrict unevenly, causing pressure buildups that force fluid through vessel walls into lung tissue. The result is a progressive drowning from the inside.

Early HAPE presents as reduced exercise tolerance and a dry cough. Advanced HAPE produces a gurgling breath, pink frothy sputum, and cyanosis the characteristic blue-grey tinge of oxygen-starved skin. Like HACE, the primary treatment is immediate descent. Supplemental oxygen, if available, can stabilise a climber long enough to descend safely. The drug nifedipine is used to reduce pulmonary artery pressure and is carried on virtually all serious high-altitude expeditions.

Supplemental Oxygen: What It Does and Doesn't Do

Most climbers on Everest use supplemental oxygen above approximately 7,000–7,500 metres. A standard flow rate of 2–4 litres per minute effectively reduces the physiological altitude experience by approximately 1,000–1,500 metres meaning that a climber at 8,848 metres breathing oxygen at 3 litres per minute is experiencing conditions roughly equivalent to 7,300–7,800 metres without oxygen.

This is significant but not transformative. The climber is still operating in conditions well beyond the safe physiological threshold. Supplemental oxygen reduces the severity of hypoxic impairment, slows the onset of fatigue, and reduces the risk of HACE and HAPE but it does not eliminate any of these risks. Running out of oxygen above 8,000 metres is a medical emergency.

The Body After Everest

Climbers who return from Everest are typically physiologically depleted in ways that take months to fully reverse. Weight loss of 5–15 kg over a 60-day expedition is common. Muscle mass decreases significantly above 6,000 metres as the body catabolises protein for fuel. The immune system, suppressed by sustained stress and extreme cold, often allows opportunistic infections to take hold after descent.

The brain may also carry subtle, long-term changes. Neuroimaging studies of high-altitude climbers have documented measurable white matter abnormalities in a proportion of subjects — the neurological signature of repeated hypoxic exposure. The evidence here is still being evaluated, but it has changed the way serious climbers think about frequency and duration of extreme-altitude exposure.

The death zone does not allow humans to live in it. It only allows them to pass through briefly, carefully, and at considerable cost.